Baseline CT imaging features combined with clinical indicators predict prognosis in unresectable HCC treated with HAIC plus targeted therapy and immunotherapy

Puntos clave

• This research aims to evaluate how baseline CT imaging features and clinical indicators can predict prognosis in patients with unresectable hepatocellular carcinoma (HCC) treated with a combination of HAIC, targeted therapy, and immunotherapy.
• Analyzed baseline CT imaging features in patients with unresectable HCC.
• Assessed clinical indicators and treatment responses.
• Compared survival outcomes between early treatment responders and non-responders.
• Early treatment responders exhibited significantly better survival rates compared to non-responders.
• Non-responders did not experience meaningful survival benefits despite receiving additional HAIC treatment cycles.